Which of the following is a key factor to consider when developing a diagnostically useful IHC assay?

• A. Tissue fixation process
• B. Flow cytometry analysis
• C. Chromatographic purification
• D. RNA sequencing

Answer: (A)

In diagnostic IHC, preserving the tissue so that the target antigen remains accessible to antibodies while the cellular architecture is still interpretable is essential. The fixation step, usually with formalin, crosslinks proteins to lock in tissue structure and stabilize antigens. Proper fixation preserves epitopes long enough for reliable antibody binding, while avoiding excessive crosslinking that can hide epitopes. If fixation is too weak, tissue degrades or antigens are lost; if it’s too strong, epitopes become masked and staining becomes faint or inconsistent. This balance directly controls the sensitivity, specificity, and reproducibility of the assay across samples and conditions, making fixation the key factor in a diagnostically useful IHC assay. The other options relate to different technologies or processes (flow cytometry, chromatographic purification, RNA sequencing) and do not determine IHC performance in tissue sections.